| SDYAX | VFIAX | SDYAX / VFIAX | |
| Total Expense Ratio | 0.75 | 0.04 | 1,875% |
| Annual Report Gross Expense Ratio | 1.18 | 0.04 | 2,950% |
| Fund Existence | 11 years | 26 years | - |
| Gain YTD | 8.725 | 9.464 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 3000 | 3,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 837M | 1.67T | 0% |
| Annual Yield % from dividends | 1.42 | 1.06 | 134% |
| Returns for 1 year | -0.34 | 18.19 | -2% |
| Returns for 3 years | 17.72 | 63.87 | 28% |
| Returns for 5 years | 5.59 | 70.57 | 8% |
| Returns for 10 years | 116.93 | 247.71 | 47% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SLCGX | 30.83 | 0.26 | +0.85% |
| Saratoga Large Capitalization Growth I | |||
| WBCIX | 18.73 | 0.06 | +0.32% |
| William Blair Small-Mid Cap Core I | |||
| PYCGX | 32.90 | -0.08 | -0.24% |
| Victory Pioneer Mid Cap Value Y | |||
| ERASX | 39.01 | -0.26 | -0.66% |
| Eaton Vance Atlanta Capital SMID-Cap R6 | |||
| FBTAX | 45.16 | -1.10 | -2.38% |
| Fidelity Advisor Biotechnology A | |||